Obesity and Substance Misuse: Is There a Relationship?

| October 22, 2013 | 0 Comments

Sansone Artworkby Randy A. Sansone, MD, and Lori A. Sansone, MD
R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, OH, and Director of Psychiatry Education at Kettering Medical Center in Kettering, OH. L. Sansone is a civilian family medicine physician and Medical Director of the Family Health Clinic at Wright-Patterson Air Force Base Medical Center in WPAFB, OH. The views and opinions expressed in this article are those of the authors and do not reflect the official policy or position of the United States Air Force, Department of Defense, or United States Government.

Innov Clin Neurosci. 2013;10(9–10):30–35

This ongoing column is dedicated to the challenging clinical interface between psychiatry and
primary care—two fields that are inexorably linked.

Funding: There was no funding for the development and writing of this article.

Financial Disclosures: The authors have no conflicts of interest relevant to the content of this article.

Key words: Alcohol, drugs, obesity, overweight, substance abuse, substance misuse, substance use disorder

The relationship between obesity and alcohol/drug misuse has been examined through both site studies and large epidemiological studies. In reviewing 19 site studies that have examined alcohol misuse among the obese, in comparison with rates before 1990, rates since 1990 have doubled (6.2% to 14.3%). Of the 7 studies that have examined drug misuse among the obese, rates average 8.0%. Given the potential limitations of varying study populations, methodologies, and prevalence assessments, these rates closely reflect those in the general population, according to data from the National Comorbidity Survey Replication study. As for the findings from 5 large epidemiological studies, 4 studies reported rates of substance misuse among the obese that were equal to or less than the general population, but one study reported higher rates (specifically in men). Overall, findings do not clearly support the contention that obese individuals are at a higher risk for substance misuse, although specific sub-populations of the obese may be (e.g., those with Cluster B personality disorders). If there is an association between some obese populations and substance abuse, this may be accounted for by overlapping neurohormonal correlates. However, some authorities contend that food and drugs compete for the same reward pathways in the brain, suggesting that obesity may actually be protective against substance misuse.

Obesity is a major health concern in the United States and affects 35.7 percent of adults and approximately 17 percent of children.1 In turn, according to data from the National Comorbidity Survey Replication study, substance use disorders affect a significant minority of the general population.2 According to data from this study, which were collected in a community sample during the years 2001–2003, the prevalence of alcohol abuse is 13.2 percent, alcohol dependence 5.4 percent, drug abuse 7.9 percent, drug dependence 3.0 percent, and any substance use disorder 14.6 percent. In examining relationships between obesity and substance misuse, according to Acosta et al,3 there are numerous parallels, including genetic predisposition, personality factors, environmental risk factors, and common neurobiological pathways in the brain. In this edition of The Interface, we present data on the comorbidity between obesity and substance use disorders and further examine this relationship.

The Literature Review
Through a literature search of the PubMed and PsycINFO databases, we explored studies examining the prevalence of alcohol and/or drug misuse in various samples of obese individuals. In using these search engines, we entered terms such as “obesity, alcohol, alcohol abuse, drug,” and “drug abuse,” and also examined reference lists within identified articles for additional articles. We did not include articles in which the study population was limited solely to individuals suffering from binge eating disorder. Likewise, we did not include articles that were written in another language or did not provide an explicit percentage with regard to prevalence rates (e.g., one article indicated that the prevalence rate was less than 2.5%). While we may have missed some articles, from our review of the literature, we believe that we have identified a robust number of source articles for this review.
site studies

To summarize these data, over the past 50 years, a number of site studies (i.e., investigations in a single institution or several institutions) have examined the prevalence of alcohol and/or drug misuse in various obese populations (Table 1).4–22 Of the 19 studies that we encountered, 11 (57.9%) consisted of subjects recruited from bariatric surgery settings.

With regard to alcohol misuse, there appear to be two distinct study eras: one era before 1990 and the other era from 1990 onward. Prior to 1990, the average prevalence of alcohol misuse (using the highest reported percentage for current, lifetime, or prevalence timeframe unclear) in the eight relevant studies is 6.2 percent, with a range from 0.9 to 20.0 percent.8,9 From 1990 onward, the average prevalence of alcohol misuse in the eight corresponding studies is 14.3 percent, with a range from 1.4 to 32.0 percent.[13,17] In other words, during this later time period, the prevalence rate of alcohol misuse among obese study participants more than doubled.

The explanation for the observed increase in the prevalence rate of alcohol misuse between these two study eras remains unclear. Perhaps the difference reflects a reduced candor of pre-1990 patients with regard to their willingness to disclose personal information (i.e., was there a general patient concern that an unfavorable admission to alcohol or drug misuse might result in surgery refusal?). Also, note that while the studies before 1990 and 1990-after have approximately equal rates of bariatric surgery sites, the total numbers of evaluated bariatric surgery candidates during these two time periods are vastly different (295 vs. 1,133); perhaps the difference in volumes explains the difference in reported rates of alcohol misuse. Another possibility may be that over the past 50 years, the assessment strategy for alcohol and drug misuse has improved, resulting in the illusion of higher prevalence rates during the later time era. A final possibility may be that alcohol and drug misuse has genuinely increased in the general population, resulting in a corresponding inflation of the prevalence rate of misuse among the obese during the second research era.

As for drug misuse, we located seven studies since 1981 reporting prevalence rates. In summarizing these findings, we excluded percentages for “substance use disorders” due to our concern that these might include alcohol misuse, rather than solely represent rates for drug misuse. As in the previous analysis, we used the highest prevalence rate per study if two or more rates were indicated, regardless of current, lifetime, or prevalence timeframe unclear. In doing so, the rate for drug misuse among the obese over the past 30 years is 8.0 percent, with a range from 0.99 to 10.0 percent.[8] In comparison with rates for alcohol misuse, the rates for drug misuse are somewhat lower.

In comparing the preceding findings with data from the National Comorbidity Survey Replication study,2 which provides community reference rates for various psychiatric syndromes and disorders, there appear to be few differences in prevalence rates (Table 2). However, the difficulty in fully interpreting these data is the lack of specificity in studies of the obese with regard to abuse versus dependence as well as varying prevalence assessments.

Large-Scale Epidemiological Studies
In more recent years, investigators have examined large epidemiologic studies to investigate relationships between obesity and alcohol/drug misuse. For example, using a cross-sectional nationally representative sample of 9,125 adults in the United States, Simon et al23 compared the prevalence rates of substance use disorders in participants with a body mass index of less than 30 to participants with a body mass index of greater than 30; rates were 4.3 percent and 2.9 percent, respectively. Using data from the National Epidemiologic Survey on Alcohol and Related Conditions, Pickering et al24 compared odds ratios for past-year psychiatric diagnoses among participants with healthy weights (n=5,984), and participants who were overweight (n=7,814), obese (n=3,856), and extremely obese (n=354). Rates for alcohol and drug use disorders were not statistically significantly different among the groups, with the exception of drug dependence, which was actually lower in the obese subsample. Scott et al25 examined 12,992 individuals in New Zealand and found no relationships between obesity and alcohol or drug use disorders. In examining data from the World Mental Health Surveys, Scott et al26 found no relationship between obesity and alcohol use disorders. Finally, in a study that examined data from the Collaborative Psychiatric Epidemiology Surveys, Rosen-Reynoso et al27 found odds ratios of less than 1.0 in all ethnic groups with regard to relationships between body mass index and substance use disorders over the past 12-months. In contrast to the preceding findings, through reanalyzed data from the National Epidemiological Survey on Alcohol and Related Conditions, Barry and Petry28 reported that overweight and obesity were associated with an increased risk for lifetime alcohol abuse/dependence in men (not women), but that body mass index was not associated with illicit drug use disorders.

Our review of the literature, which includes both site studies and large epidemiological studies, did not reveal a consistently evident relationship between obesity and substance use disorders. However, some individual studies/samples did evidence such a relationship. For these latter studies, which appear to be in the minority, there may be several lines of adjuvant support. For example, Grucza et al29 found epidemiological support for a link between familial alcoholism risk and obesity in women as well as possibly men. Using data from the National Epidemiologic Survey on Alcohol and Related Conditions, Gearhardt and Corbin30 suggested a neurobiological link between food consumption and alcohol use. Suter31 found that alcohol calories count more in moderation than in heavy use, indicating that periodic excessive alcohol use may directly contribute to excess calories and weight gain. In contrast, Kleiner et al32 found a significant inverse relationship between body mass index and alcohol consumption. Indeed, other authorities emphasize that there are many inconsistencies in the addiction model of eating disorders,33 and while there may be some shared neurohormonal pathways, there appear to be distinct variations, as well.[34]

As for the general impression that there is not a relationship between obesity and substance use disorders, Warren and Gold35 report that food and drugs may be competing for the same reward sites in the brain. In support of this perspective, they found among women that as body mass index increased, alcohol consumption in the past year decreased.[35]

There have been numerous studies on the relationship between obesity and substance use disorders. For alcohol misuse, comparing studies prior to 1990 with studies from 1990-onward, there appears to be a doubling of prevalence rates in the obese in site studies. However, rough averages of the prevalence rates of both alcohol and drug misuse among the obese in site studies closely parallel rates reported in the National Comorbidity Survey Replication data. In addition, in large epidemiological studies, four of five studies found no relationship between obesity and substance misuse. Still, some studies evidence unexpectedly high rates of substance misuse among the obese. These inconsistencies may reflect specific population characteristics and/or methodological variations. Overall, a conservative conclusion appears to be that while there may be some specific obese populations with higher rates of substance misuse, the data generally indicate equal or even lower rates of substance misuse in the obese compared with the general population. Only further research will verify these conclusions.

1. Centers for Disease Control and Prevention. Obesity and overweight for professionals: data and statistics. http://www.cdc.gov/obesity/data/trends.HTML. Accessed on March 13, 2012.
2. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
3. Acosta MC, Manubay J, Levin FR. Pediatric obesity: parallels with addiction and treatment recommendations. Harv Rev Psychiatry. 2008;16:80–96.
4. Mendelson M, Weinberg N, Stunkard AJ. Obesity in men: a clinical study of twenty-five cases. Ann Intern Med. 1961;54:660–671.
5. Reivich RS, Ruiz RA, Lapi RM. Extreme obesity—psychiatric, psychometric and psychotherapeutic aspects. J Kans Med Soc. 1966;67:134–140.
6. Atkinson RM, Ringuette EL. A survey of biographical and psychological features in extraordinary fatness. Psychosom Med. 1967;29:121–133.
7. Swanson DW, Dinello FA. Severe obesity as a habituation syndrome. Evidence during a starvation study. Arch Gen Psychiatry. 1970;22:120–127.
8. Kalucy RS, Crisp AH. Some psychological and social implications of massive obesity. A study of some psychosocial accompaniments of major fat loss occurring without dietary restriction in massively obese patients. J Psychosom Res. 1974;18:465–473.
9. Hutzler JC, Keen J, Molinari V, Carey L. Super-obesity: a psychiatric profile of patients electing gastric stapling for the treatment of morbid obesity. J Clin Psychiatry. 1981;42:458–462.
10. Gentry K, Halverson JD, Heisler S. Psychological assessment of morbidly obese patients undergoing gastric bypass: a comparison of preoperative and postoperative adjustment. Surgery. 1984;95:215–220.
11. Dubovsky SL, Haddenhorst A, Murphy J, Liechty RD, Coyle DA. A preliminary study of the relationship between preoperative depression and weight loss following surgery for morbid obesity. Int J Psychiatry Med. 1985-1986;15:185–196.
12. Gertler R, Ramsey-Stewart G. Pre-operative psychiatric assessment of patients presenting for gastric bariatric surgery (surgical control of morbid obesity). Aust N Z J Surg. 1986;56:157–161.
13. Marcus MD, Wing RR, Ewing L, et al. Psychiatric disorders among obese binge eaters. Int J Eat Disord. 1990;9:69–77.
14. Black DW, Goldstein RB, Mason EE. Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients. Am J Psychiatry. 1992;149:227–234.
15. Yanovski SZ, Nelson JE, Dubbert B, Spitzer RL. Association of binge eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry. 1993;150:1472–1479.
16. Specker S, de Zwaan M, Raymond N, Mitchell J. Psychopathology in subgroups of obese women with and without binge eating disorder. Compr Psychiatry. 1994;35:185–190.
17. Ricca V, Mannucci E, Moretti S, et al. Screening for binge eating disorder in obese outpatients. Compr Psychiatry. 2000;41:111-115.
18. Mitchell JE, Lancaster KL, Burgard MA, et al. Long-term follow-up of patients’ status after gastric bypass. Obes Surg. 2001;11:464–468.
19. Rosenberger PH, Henderson KE, Grilo CM. Psychiatric disorder comorbidity and association with eating disorders in bariatric surgery patients: a cross-sectional study using structured interview-based diagnosis. J Clin Psychiatry. 2006;67:1080–1085.
20. Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry. 2007;164:328–334.
21. Ertelt TW, Mitchell JE, Lancaster K, et al. Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set. Surg Obes Relat Dis. 2008;4:647–650.
22. Heinberg LJ, Ashton K. History of substance abuse relates to improved postbariatric body mass index outcomes. Surg Obes Relat Dis. 2010;6:417–421.
23. Simon GE, Von Korff M, Saunders K, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63:824–830.
24. Pickering RP, Grant BF, Chou SP, Compton WM. Are overweight, obesity, and extreme obesity associated with psychopathology? Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2007;68:998–1009.
25. Scott KM, McGee MA, Wells E, Oakley Browne MA. Obesity and mental disorders in the adult general population. J Psychosom Res. 2008;64:97–105.
26. Scott KM, Bruffaerts R, Simon GE, et al. Obesity and mental disorder in the general population: results from the World Mental Health Surveys. Int J Obes. 2008;32:192–200.
27. Rosen-Reynoso M, Alegria M, Chen C-N, Laderman M, Roberts R. The relationship between obesity and psychiatric disorders across ethnic and racial minority groups in the United States. Eat Behav. 2011;12:1–8.
28. Barry D, Petry NM. Associations between body mass index and substance use disorders differ by gender: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addict Behav. 2009;34:51-60.
29. Grucza RA, Krueger RF, Racette SB, et al. The emerging link between alcoholism risk and obesity in the United States. Arch Gen Psychiatry. 2010;67:1301–1308.
30. Gearhardt AN, Corbin WR. Body mass index and alcohol consumption: family history of alcoholism as a moderator. Psychol Addict Behav. 2009;23:216–225.
31. Suter PM. Is alcohol consumption a risk factor for weight gain and obesity? Crit Rev Clin Lab Sci. 2005;42:197–227.
32. Kleiner KD, Gold MS, Frost-Pineda K, et al. Body mass index and alcohol use. J Addict Dis. 2004;23:105–118.
33. Wilson GT. Eating disorders, obesity and addiction. Eur Eat Disord Rev. 2010;18:341–351.
34. Liu Y, von Deneen KM, Kobeissy FH, Gold MS. Food addiction and obesity: evidence from bench to bedside. J Psychoactive Drugs. 2010;42:133–145.
35. Warren MW, Gold MS. The relationship between obesity and drug use. Am J Psychiatry. 2007;164:1268.

Tags: , , , , , ,

Category: Medical Issues, Primary Care, Psychiatry, Substance Use Disorders, The Interface

Leave a Reply